Jul 31, 2024
In the final episode of this two-part series, Dr. Joe Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Ravulizumab + zilucoplan.
Show...
Jul 30, 2024
In the final part of this two-part series, Dr. Andy Southerland and Dr. Lidia Moura discuss strategies on how clinicians can mitigate bias when using large language models.
Jul 29, 2024
Dr. Justin Abbatemarco, Dr. Michael R. Wilson, and Dr. John Pluvinage discuss their discovery of anti-CD320 antibodies in patients with neurologic manifestations of B12 deficiency and discuss the potential implications for diagnosis and treatment.
Show reference:
Jul 26, 2024
In part one of the part-two series, Dr. Andy Southerland and Dr. Lidia Moura discuss the major findings related to large language models (LLMs) for neurologic care.
Show reference:
Jul 25, 2024
Dr. Justin Abbatemarco, Dr. Michael R. Wilson, and Dr. John Pluvinage introduce B12 deficiency and discuss challenges in measuring B12 levels in the serum.
Show reference: